Evidence map›Paper›PMID 36839817›Full record

ArticlePharmaceutics2023

A Machine Learning Approach for PLGA Nanoparticles in Antiviral Drug Delivery.

Labiba Noorain, Vu Nguyen, Hae-Won Kim, Linh T B Nguyen

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Formulation Development andCurrent drug delivery · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Machine Learning in Polymer Research.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Labiba NoorainDepartment of Pharmaceutics, School of Pharmacy, University College London, London WC1N 1AX, UK.
Vu NguyenMachine Learning Research Group, Eagle House, University of Oxford, Oxford OX2 6ED, UK.ORCID 0000-0002-0294-4561
Hae-Won KimUCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Cheonan 31116, Republic of Korea.
Linh T B NguyenUCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Cheonan 31116, Republic of Korea.ORCID 0000-0002-8532-8296

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, nanoparticles have been highly investigated in the laboratory. However, only a few laboratory discoveries have been translated into clinical practice. These findings in the laboratory are limited by trial-and-error methods to determine the optimum formulation for successful drug delivery. A new paradigm is required to ease the translation of lab discoveries to clinical practice. Due to their previous success in antiviral activity, it is vital to accelerate the discovery of novel drugs to treat and manage viruses. Machine learning is a subfield of artificial intelligence and consists of computer algorithms which are improved through experience. It can generate predictions from data inputs via an algorithm which includes a method built from inputs and outputs. Combining nanotherapeutics and well-established machine-learning algorithms can simplify antiviral-drug development systems by automating the analysis. Other relationships in bio-pharmaceutical networks would eventually aid in reaching a complex goal very easily. From previous laboratory experiments, data can be extracted and input into machine learning algorithms to generate predictions. In this study, poly (lactic-co-glycolic acid) (PLGA) nanoparticles were investigated in antiviral drug delivery. Data was extracted from research articles on nanoparticle size, polydispersity index, drug loading capacity and encapsulation efficiency. The Gaussian Process, a form of machine learning algorithm, could be applied to this data to generate graphs with predictions of the datasets. The Gaussian Process is a probabilistic machine learning model which defines a prior over function. The mean and variance of the data can be calculated via matrix multiplications, leading to the formation of prediction graphs-the graphs generated in this study which could be used for the discovery of novel antiviral drugs. The drug load and encapsulation efficiency of a nanoparticle with a specific size can be predicted using these graphs. This could eliminate the trial-and-error discovery method and save laboratory time and ease efficiency.

Indexed as

antiviralmachine learningnanoparticlesPLGA

Identifiers

PMID36839817
PMCPMC9966002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.